Canada’s regulatory approach to drugs for rare diseases: orphan drugs
Canada’s regulatory approach to drugs for rare diseases: orphan drugs is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2023-12-02. On CanQuery you can follow the original downloads. Files are available in English and French.
Canada's regulatory approach: Drugs for rare diseases are authorized for sale in Canada under the Food and Drugs Act and Part C of the Food and Drug Regulations.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-12-02
Data overview
- Formats
- HTML
- File languages
- English, French